Virginia Retirement Systems ET AL acquired a new position in shares of Core Laboratories N.V. (NYSE:CLB) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 37,500 shares of the oil and gas company’s stock, valued at approximately $3,798,000. Virginia Retirement Systems ET AL owned about 0.08% of Core Laboratories N.V. as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CLB. Creative Planning increased its stake in shares of Core Laboratories N.V. by 1.9% in the first quarter. Creative Planning now owns 1,730 shares of the oil and gas company’s stock valued at $200,000 after buying an additional 33 shares in the last quarter. ProShare Advisors LLC increased its stake in shares of Core Laboratories N.V. by 8.5% in the first quarter. ProShare Advisors LLC now owns 3,802 shares of the oil and gas company’s stock valued at $439,000 after buying an additional 297 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in shares of Core Laboratories N.V. by 42.7% in the first quarter. Janney Montgomery Scott LLC now owns 11,367 shares of the oil and gas company’s stock valued at $1,313,000 after buying an additional 3,404 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD increased its stake in shares of Core Laboratories N.V. by 21.5% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 3,684 shares of the oil and gas company’s stock valued at $425,000 after buying an additional 653 shares in the last quarter. Finally, Parsons Capital Management Inc. RI increased its stake in shares of Core Laboratories N.V. by 15.4% in the first quarter. Parsons Capital Management Inc. RI now owns 10,436 shares of the oil and gas company’s stock valued at $1,206,000 after buying an additional 1,394 shares in the last quarter.

Core Laboratories N.V. (NYSE:CLB) opened at 89.61 on Monday. The stock has a market capitalization of $3.96 billion, a P/E ratio of 54.98 and a beta of 1.60. Core Laboratories N.V. has a 52-week low of $87.83 and a 52-week high of $125.83. The company’s 50-day moving average price is $98.61 and its 200 day moving average price is $106.75.

Core Laboratories N.V. (NYSE:CLB) last issued its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The business had revenue of $163.90 million for the quarter, compared to analyst estimates of $168.23 million. During the same period in the previous year, the business posted $0.35 earnings per share. The business’s revenue was up 10.7% compared to the same quarter last year. On average, equities research analysts predict that Core Laboratories N.V. will post $2.09 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, August 14th. Stockholders of record on Monday, July 17th were paid a dividend of $0.55 per share. The ex-dividend date was Thursday, July 13th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.46%. Core Laboratories N.V.’s dividend payout ratio (DPR) is 134.15%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://theolympiareport.com/2017/08/28/virginia-retirement-systems-et-al-acquires-shares-of-37500-core-laboratories-n-v-clb.html.

CLB has been the topic of several recent analyst reports. Piper Jaffray Companies set a $97.00 target price on Core Laboratories N.V. and gave the company a “hold” rating in a research note on Wednesday, July 26th. Citigroup Inc. cut their target price on Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 26th. ValuEngine upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. Royal Bank Of Canada set a $145.00 target price on Core Laboratories N.V. and gave the company a “buy” rating in a research note on Saturday, June 17th. Finally, Zacks Investment Research downgraded Core Laboratories N.V. from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $116.75.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.